Suchergebnisse

Social marketing is acquiring a familiar ring to people in the health sector. The UK government's recent public health white paper talks of the "power of social marketing" and "marketing tools applied to social good [being] used to build public awareness and change behaviour." This has led to the formation of the National Social Marketing Centre for Excellence, a collaboration between the Department of Health and the National Consumer Council. The centre will develop the first social marketing strategy for health in England. Similarly, the Scottish Executive recently commissioned an investigation into how social marketing can be used to guide health improvement. Australia, New Zealand, Canada, and the United States all have social marketing facilities embedded high within their health services. Evans has outlined social marketing's basic precepts. We develop some of these ideas and suggest how social marketing can help doctors and other health professionals to do their jobs more effectively.

Contentious commodities such as tobacco, alcohol and fatty foods are bringing marketing under scrutiny from consumers and policymakers. Yet there is little agreement on whether marketing is harmful to society. Systematic review (SR), a methodology derived from clinical medicine, offers marketers a tool for providing resolution and allowing policymakers to proceed with greater confidence. This article describes how SR methods were applied for the first time to a marketing problem — the effects of food promotion to children. The review withstood scrutiny and its findings were formally ratified by government bodies and policymakers, demonstrating that SR methods can transfer from clinical research to marketing.

Abstract

In recent years, the marketing practices of the pharmaceutical industry have been subject to scrutiny and criticism. In the UK, prescription‐only (PO) medicines cannot be marketed directly to the public, and marketing to health professionals is self‐regulated by the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice.
This study uses internal document analyses to examine the effectiveness of this regulatory framework. Specifically, a qualitative analysis was conducted of internal marketing documents from five UK pharmaceutical companies which were obtained by the House of Commons Health Committee. This analysis suggests that major pharmaceutical companies are contravening the ABPI Code in four key areas.
The authors conclude that the current system is not effectively regulating the marketing of PO medicines to the general public or health professionals in the UK and suggest that the Code and indeed the whole regulatory procedure needs a thorough review.

Copyright © 2007 John Wiley & Sons, Ltd.

Given the inequitable distribution of resources across school, neighborhood, and home contexts in the United States, lower resourced students may have had fewer opportunities to learn during the coronavirus disease 2019 pandemic, which may have caused previous disadvantages to accumulate during the pandemic. Nevertheless, research has yet to comprehensively explore how school, neighborhood, and home contexts— together—relate to perceptions of school quality and, ultimately, learning outcomes during the pandemic. To fill this gap, the authors leverage a unique multiwave survey of households across 47 states. Using multinomial modeling, the authors find that previous disadvantages were not always accumulated during the pandemic and that in some cases, perceptions of school quality and student learning improved for students who had struggled before the pandemic. The results also suggest stratification across race/ethnicity, parental education levels, school types, learning modes, and a range of learning resources.